Recent research was published on surveillance of equine influenza in the United States by Nicola Pusterla, DrMedVeT, MedVet, of the University of California, Davis, College of Veterinary Medicine, and his colleagues.
The article was published in the Journal of Veterinary Internal Medicine, and because it is part of the Open access in Wiley.com’s online library, which means you can read the entire research paper online.
Following is the abstract of the paper.
Recent surveillance studies for equine respiratory viruses have shown that equine influenza virus (EIV) continues to be a prevalent respiratory virus of equids throughout the United States and Europe.
To gain a better understanding of the prevalence and epidemiology of EIV shed by horses, mules and donkeys in the United States from March 2010 to November 2013.
Nasal secretions from index cases with acute onset of respiratory disease were tested by qPCR for EIV. Multilevel logistic regression was used to model the association between EIV status and prevalence factors. Furthermore, observations from EIV-positive study horses were compared to previous data from March 2008 to February 2010.
A total of 230 (9.7%) index cases tested qPCR positive for EIV. A higher-than-expected proportion of EIV qPCR-positive horses occurred in the 1–5, 6–10, and 11–15 age groups when compared to the <1 year of age group. Fever, nasal discharge and coughing were positively associated with EIV-positive horses. EIV qPCR-positive study cases were significantly older and more often vaccinated against EIV compared to EIV qPCR-positive animals from the 2008-2010 study period.
Conclusions and Clinical Importance
This study provides valuable and contemporary information on the frequency of EIV detected by qPCR in the United States. The results also underscore that older and previously vaccinated horses were susceptible to EIV.
N. Pusterla, S. Mapes, C. Waderman, and N. Akana, Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA; P.H. Kass, Department of Population Health and Reproduction (Kass), School of Veterinary Medicine, University of California, Davis; C. Barnett, C. MacKenzie, and W. Vaala, Merck Animal Health, Summit, NJ.